Connection
Sarah Rhoads to Anti-Asthmatic Agents
This is a "connection" page, showing publications Sarah Rhoads has written about Anti-Asthmatic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.281 |
|
|
|
-
Rhoads SL, Seluk L, Wechsler ME. Asthma therapeutics: Past, present, and future. Pharmacol Rev. 2025 07; 77(4):100062.
Score: 0.730
-
Davis AE, Rhoads S, Wechsler ME. Emerging biologic targets in type 2 and non-type 2 asthma. Curr Opin Pulm Med. 2026 May 01; 32(3):210-219.
Score: 0.193
-
Eggert L, Rhoads S, Wechsler ME, Akuthota P. Con: clinical remission in asthma - not yet there. Eur Respir Rev. 2025 Apr; 34(176).
Score: 0.182
-
Seluk L, Davis AE, Rhoads S, Wechsler ME. Novel asthma treatments: Advancing beyond approved novel step-up therapies for asthma. Ann Allergy Asthma Immunol. 2025 01; 134(1):9-18.
Score: 0.176